Notice2024-05774
Notice of Award of a Sole Source Cooperative Agreement To Fund World Health Organization (WHO)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 19, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $20,000,000, for Year 1 funding to WHO. This award will support the development of global guidelines and provide technical assistance through WHO to aid PEPFAR-supported countries to meet the 95-95-95 targets and achieve program sustainability by 2030. Funding amounts for years 2-5 will be set at continuation.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 54 (Tuesday, March 19, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 54 (Tuesday, March 19, 2024)]
[Notices]
[Pages 19593-19594]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-05774]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Sole Source Cooperative Agreement To Fund
World Health Organization (WHO)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $20,000,000, for Year 1 funding to WHO. This
award will support the development of global guidelines and provide
technical assistance through WHO to aid PEPFAR-supported countries to
meet the 95-95-95 targets and achieve program sustainability by 2030.
Funding amounts for years 2-5 will be set at continuation.
DATES: The period for this this award will be September 30, 2024,
through September 29, 2029
FOR FURTHER INFORMATION CONTACT: Francheskie Velez, Center for Global
Health, Centers for Disease Control and Prevention, 1600 Clifton Road
NE MS-E39 Atlanta, GA 30329, telephone: 404.245.5639, e-Mail:
<a href="/cdn-cgi/l/email-protection#4423342376042720276a232b32"><span class="__cf_email__" data-cfemail="89eef9eebbc9eaedeaa7eee6ff">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The sole source award will support efforts
to improve surveillance, prevention, care, and treatment of HIV,
Tuberculosis (TB), sexually transmitted infection
[[Page 19594]]
(STIs), viral hepatitis, and associated chronic co-infections and
noncommunicable diseases (NCDs); promote health equity; increase
sustainability of programs; strengthen public health systems and health
security; and follow science.
WHO is in a unique position to conduct this work, as it is the sole
international global health organization responsible for issuing
normative standard and guidelines for implementation of health programs
including HIV/AIDS within the UN system. No other organization has the
authority to issue international standards for health in the UN system
as denoted by the WHO constitution signed in 1948.
Summary of the Award
Recipient: World Health Organization (WHO).
Purpose of the Award: The purpose of this award is to support the
development of global guidelines and provide technical assistance
through WHO to aid PEPFAR-supported countries to meet the 95-95-95
targets and achieve program sustainability by 2030. In alignment with
the 2022 PEPFAR Five-Year Strategy.
Amount of Award: For WHO, the approximate year 1 funding amount
will be $20,000,000 in Federal Fiscal Year (FYY) 2024 funds, subject to
the availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Authority: This program is authorized under Public Law 108-25 (the
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act
of 2003) (22 U.S.C. 7601, et seq.) and Public Law 110-293 (the Tom
Lantos and Henry J. Hyde United States Global Leadership Against HIV/
AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008), and
Public Law 113-56 (PEPFAR Stewardship and Oversight Act of 2013).
Additionally, this program is authorized under section 307 of the
Public Health Service Act (42 U.S.C. 242l), as amended and section
301(a) of the Public Health Service Act (42 U.S.C. 241(a)), as amended.
Non-PEPFAR Funding
Additionally, this program is authorized under the Public Health
Service Act 42 CFR part 51b--Project Grants for Preventive Health
Services section 318 (42 U.S.C. 247c) section 318 (42 U.S.C. 247c)
Sexually transmitted diseases; prevention and control projects;
sections 301(a), 317N, and 318 of the Public Health Service Act (42
U.S.C. 241(a), 247b-15, and 247c).
Period of Performance: The period for this award will be September
30, 2024, through September 29, 2029.
Dated: March 13, 2024.
Jamie Legier,
Acting Director, Office of Grants Services, Centers for Disease Control
and Prevention.
[FR Doc. 2024-05774 Filed 3-18-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 19, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.